Literature DB >> 16941331

First outbreak of colonization and infection with vancomycin-resistant Enterococcus faecium in a tertiary care hospital in Singapore.

Maciej Piotr Chlebicki1, Moi Lin Ling, Tse Hsien Koh, Li Yang Hsu, Ban Hock Tan, Kue Bien How, Li-Hwei Sng, Grace Chee Yeng Wang, Asok Kurup, Mei Ling Kang, Jenny Guek Hong Low.   

Abstract

We report the first outbreak of vancomycin-resistant Enterococcus faecium colonization and infection among inpatients in the hematology ward of an acute tertiary care public hospital in Singapore. Two cases of bacteremia and 4 cases of gastrointestinal carriage were uncovered before implementation of strict infection control measures resulted in control of the outbreak.

Entities:  

Mesh:

Year:  2006        PMID: 16941331     DOI: 10.1086/507289

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  4 in total

1.  Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic review.

Authors:  Nikos Ulrich; Ralf-Peter Vonberg; Petra Gastmeier
Journal:  Heliyon       Date:  2017-12-28

2.  Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient.

Authors:  Ivana Goić-Barišić; Marina Radić; Anita Novak; Žana Rubić; Nataša Boban; Boris Lukšić; Marija Tonkić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

Review 3.  Where is the difference between an epidemic and a high endemic level with respect to nosocomial infection control measures? An analysis based on the example of vancomycin-resistant Enterococcus faecium in hematology and oncology departments.

Authors:  Nikos Ulrich; Petra Gastmeier
Journal:  GMS Hyg Infect Control       Date:  2017-08-28

4.  Control of a hospital-wide vancomycin-resistant Enterococci outbreak.

Authors:  Asok Kurup; M P Chlebicki; M L Ling; T H Koh; K Y Tan; L C Lee; K B M Howe
Journal:  Am J Infect Control       Date:  2008-04       Impact factor: 2.918

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.